Association of interleukin-13/-4 and toll-like receptor 10 with preterm births

Andrea Heinzmann1, Beena Mailaparambil, Nadja Mingirulli

  • 1Centre for Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany. andrea.heinzmann@uniklinik-freiburg.de

Neonatology
|April 1, 2009
PubMed

Insights

Genetic factors like interleukin (IL)-13/IL-4 and Toll-like receptor (TLR)-10 haplotypes may predispose to preterm birth (PTB). Further research into these genetic links could reveal new prevention strategies for PTB.

Area of Science:

  • Genetics
  • Neonatal Medicine
  • Immunology

Background:

  • Preterm birth (PTB) is a significant cause of neonatal morbidity.
  • The etiology of PTB is multifactorial, involving complex interactions between maternal and fetal genetic and environmental factors.
  • Identifying genetic predispositions is crucial for understanding PTB risk.

Purpose of the Study:

  • To identify fetal genes associated with an increased risk of preterm birth (PTB) in the German population.
  • To investigate the role of specific genetic polymorphisms and haplotypes in PTB susceptibility.
  • To explore potential genetic targets for PTB prevention.

Main Methods:

  • Screening of 31 polymorphisms in 15 genes among 121 preterm infants and 270 controls.
  • Genotyping using restriction fragment length polymorphism (RFLP).
  • Statistical analysis employing Armitage's trend test and haplotype analysis with FAMHAP.

Main Results:

  • No single polymorphism was significantly associated with PTB.
  • Haplotypes of interleukin (IL)-13/IL-4 and Toll-like receptor (TLR)-10 showed significant association with PTB (p = 0.0001 and p = 0.0011, respectively).
  • Association findings were confirmed in an extended cohort, and a weak association for one IL-13 polymorphism was observed (p = 0.031).

Conclusions:

  • Interleukin (IL)-13/IL-4 and Toll-like receptor (TLR)-10 genetic variants may play a role in the pathophysiology of preterm birth (PTB).
  • Dissecting the genetic underpinnings of PTB is essential for a comprehensive understanding of its development.
  • Identifying genetic factors could lead to novel therapeutic targets for PTB prevention.
Abstract